All products are sold strictly for laboratory research use only. Not for human or veterinary consumption, diagnosis, or treatment. Not approved by the FDA.

Research Use Only

Search results for "LC-MS"

Found 4 products

4 results

Sort by:

Epitalon

SKU RP-EPIT

Epitalon

AEDG Tetrapeptide: 4-amino acid sequence (Ala-Glu-Asp-Gly), ≥98% purity by HPLC
hTERT / Telomerase Research: Telomerase reverse transcriptase upregulation studies
Pineal AANAT Studies: Arylalkylamine-N-acetyltransferase and pCREB signaling research

$37.00

GHK-Cu (50 mg)

SKU RP-GHK-50MG

GHK-Cu (50 mg)

Copper Tripeptide-1: Gly-His-Lys copper(II) complex, ≥98% purity by HPLC, naturally occurring plasma peptide
Broad Gene Regulation: Modulates 31.2% of human genes (>4,000 genes) including TGF-β/Smad pathway activation
ECM and Tissue Research: Collagen synthesis, MMP modulation, anti-inflammatory, and antioxidant pathway studies

$39.00

GHK-Cu Capsules (3mg) 60 capsules

SKU RP-GHK-3MG

GHK-Cu Capsules (3mg) 60 capsules

GHK-Cu Oral Capsules: Gly-His-Lys copper(II) complex, 3mg/capsule × 60, ≥98% purity by HPLC
TGF-β / NF-κB Pathway Research: ECM remodeling, NF-κB anti-inflammatory signaling studies
Oral Pharmacokinetics Studies: GI bioavailability and SIRT1/STAT3 colitis-model research

$84.00

Thymosin Alpha-1

SKU RP-THYM

Thymosin Alpha-1

28-Amino Acid Immunomodulator: N-terminal fragment of prothymosin alpha (Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN); CAS 62304-98-7; MW 3,108.28 Da; ≥95% HPLC purity; 3,000+ PubMed publications; N-terminal acetylation confers resistance to aminopeptidase degradation
Pleiotropic Immune Signaling Research: TLR2/TLR3/TLR4/TLR7/TLR9 agonist; dendritic cell maturation (MHC-II, CD80/CD86/CD40 upregulation); T-cell differentiation (CD4+/CD8+); Th1 polarization (IL-2/IL-12/IFN-γ); NK cell activation; PD-1/Tim-3 exhaustion marker regulation
Broad Clinical Investigation: Thymalfasin (Zadaxin) — pharmaceutical with this amino acid sequence — is approved in 35+ countries; clinical investigation in COVID-19 lymphocytopenia (Liu et al., 2020), sepsis immunology meta-analyses (Liu et al., 2016; Tian et al., 2025), HBV/HCC biology, and vaccine adjuvancy research

$54.00